fluticasone

Food and Drug Administration (FDA) in 1998 and 2004 respectively, Serevent and Flovent HFA are commonly used, making it likely that many COPD patients may already benefit from the protective effect seen in the study.

Fluticasone propionate (Flovent HFA, Flovent Diskus) is a synthetic glucocorticoid with high topical antiinflammatory potency and is available in MDI and DPI form.

A new dose counter is available on two formulations of fluticasone propionate: Flovent HFA 44-meg inhalation aerosol and Flovent Diskus 50-meg inhalation powder.

(dose counting device for fluticasone propionate, GlaxoSmithKline Inc.) A new dose counter is available on two formulations of fluticasone propionate: Flovent HFA 44-mcg inhalation aerosol and Flovent Diskus 50-mcg inhalation powder.

Atrovent HFA is the latest inhalation aerosol approved by the Food and Drug Administration after reformulation without CFCs; others include fluticasone HFA (Flovent HFA Inhalation Aerosol, GlaxoSmithKline) and two formulations of albuterol sulfate HFA (Proventil HFA, 3M Pharmaceuticals; Ventolin HFA, GlaxoSmithKline).

The FDA approved a new indication for Flovent HFA Inhalation Aerosol for maintenance treatment of asthma in children aged 4-11 years.

Flovent HFA Inhalation Aerosol (fluticasone propionate HFA, GlaxoSmithKline)

38 Flovent HFA GlaxoSmithKline 00173071920 2,661,216

97 GlaxoSmithKline Flovent HFA 00173071920 $358,994,841